• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)

    2.935 +0.045 (+1.56%)
    Streaming Delayed Price Updated: 12:45 PM EST, Jan 27, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Iovance Biotherapeutics, Inc. - Common Stock

    < Previous 1 2
    ...
    16 17 18 19 20 21 22 23 Next >
    News headline image
    Fisker, Iovance Biotherapeutics Lead Gains — Tesla Dips: Top 5 Trending Stocks Today ↗
     
    Via Benzinga
    News headline image
    Iovance Biotherapeutics, Inc. Announces Proposed Public Offering of Common Stock
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Iovance's Update Provides Reassurance With Upcoming Lifileucel's FDA Action Date, Analyst Says ↗
    Iovance Biotherapeutics Inc (NASDAQ: IOVA) announced regulatory and clinical updates related to its registrational single-arm Phase 2 IOV-LUN-202 trial in post-anti-PD-1  
    Via Benzinga
    News headline image
    Why Iovance Biotherapeutics (IOVA) Shares Are Exploding Higher ↗
    Iovance Biotherapeutics Inc (NASDAQ: IOVA) shares are trading higher by 14.3% to $8.28 Monday morning after the company announced regulatory, clinical updates for TIL therapy in 
    Via Benzinga
    News headline image
    Iovance Biotherapeutics Announces Regulatory and Clinical Updates for TIL Therapy in Advanced Non-Small Cell Lung Cancer
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Analyst Ratings for Iovance Biotherapeutics ↗
     
    Via Benzinga
    News headline image
    Analyst Expectations for Iovance Biotherapeutics's Future ↗
     
    Via Benzinga
    News headline image
    Why Icahn Enterprises Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
    Gainers Mobilicom Limited (NASDAQ: MOB) shares jumped 81.3% to $2.7187 after the company announced it received a commercial scale purchase order from Teledyne-FLIR for the production of drones for the... 
    Via Benzinga
    News headline image
    10 Health Care Stocks Whale Activity In Today's Session ↗
     
    Via Benzinga
    News headline image
    Iovance Biotherapeutics to Host Virtual Roundtable with Key Opinion Leaders to Discuss Melanoma Treatment Landscape
    Investor Conference Call and Webcast on June 26 at 5:00 p.m. ET 
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    News headline image
    What's Going On With Iovance Biotherapeutics Stock? ↗
    Iovance Biotherapeutics Inc (NASDAQ: IOVA) shares are trading higher Tuesday after the U.S. 
    Via Benzinga
    News headline image
    Where Iovance Biotherapeutics Stands With Analysts ↗
     
    Via Benzinga
    News headline image
    How to Trade Stocks Online the Right Way
    Learning how active trading works requires serious education, including learning how to get started. Learn how to trade stocks online on MarketBeat. 
    Via MarketBeat
    News headline image
    Iovance Biotherapeutics to Present at Jefferies Global Healthcare Conference
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Biotech Alert: Searches Spiking For These Stocks Today - Friday, June 2 ↗
    Various names in the biotech sector are seeing a substantial increase in search activity today. Such names include the likes of Akebia Therapeautics, Corvus Pharmaceuticals, and Mirati Therapeutics. 
    Via Talk Markets
    News headline image
    Why Shares of Iovance Biotherapeutics Jumped Tuesday ↗
    The company received approval for a biologics license application for an advanced melanoma therapy. 
    Via The Motley Fool
    News headline image
    Iovance Biotherapeutics Spikes on Melanoma BLA FDA Application
    Iovance Biotherapeutics Inc. (NASDAQ: IOVA) shares spiked over 20% on its advanced-stage melanoma treatment application to the U.S. Food and Drug Admin 
    Via MarketBeat
    Topics Death
    News headline image
    Analyst Ratings for Iovance Biotherapeutics ↗
     
    Via Benzinga
    News headline image
    Recap: Iovance Biotherapeutics Q1 Earnings ↗
     
    Via Benzinga
    News headline image
    Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
    Gainers QualTek Services Inc. (NASDAQ: QTEK) shares jumped 127.2% to $0.1740 after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter 11 bankruptcy. 
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Why Seelos Therapeutics Shares Are Trading Lower By 10%; Here Are 20 Stocks Moving Premarket ↗
    Gainers QualTek Services Inc. (NASDAQ: QTEK) shares rose 206.7% to $0.2350 in pre-market trading after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter... 
    Via Benzinga
    News headline image
    Gaotu Techedu, Iovance Biotherapeutics And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session ↗
    U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. Gaotu Techedu Inc. (NYSE: GOTU) shares jumped 19.7% to $2.98 in pre-market... 
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Monday's After-Market Session ↗
     
    Via Benzinga
    News headline image
    Iovance Biotherapeutics Announces U.S. Food and Drug Administration Acceptance of the Biologics License Application of Lifileucel for the Treatment of Advanced Melanoma
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Ulta Beauty, Tilray Brands And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
    U.S. stock futures traded mixed this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
    Via Benzinga
    News headline image
    Iovance Biotherapeutics Reports First Quarter 2023 Financial Results and Corporate Updates
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Iovance Biotherapeutics to Host First Quarter 2023 Financial Results Conference Call and Webcast on Tuesday, May 9, 2023
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Why Shares of Iovance Biotherapeutics Jumped Monday ↗
    The stock bounced back big from its 52-week low last week. 
    Via The Motley Fool
    News headline image
    Iovance Biotherapeutics to Present at Upcoming Conferences
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    < Previous 1 2
    ...
    16 17 18 19 20 21 22 23 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.